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Perspective: regulation of pest and disease




Pests and diseases are a continuous challenge in agriculture production. A wide range of control strategies have been and will
continue to be developed. New control strategies are in almost all countries around theworld assessed prior to approval for use
in farmers’ ﬁelds. This is rightly so to avoid and even reduce negative eﬀects for human health and the environment. Over the
past decades the approval processes have become increasingly politicized resulting in an increase in the direct approval costs
and the length in approval time without increasing the safety of the ﬁnal product. This reduces the development of control
strategies and often has negative human health and environmental eﬀects. Possibilities exist for improvements. They include
reducing approval costs and approval time by streamlining the approval process and substituting approval requirements by
strengthening ex-post liability.
© 2018 Society of Chemical Industry
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1 INTRODUCTION
The control of pests and diseases in agriculture is important. Pests
and diseases reduce crop yield and crop quality. Pest and dis-
ease management strategies include a wide range of options. In
the contextof this perspective, the focus is onbiological andchem-
ical control agents such as microbes and chemicals and pest
and disease-resistant plants. Cultivation practices such as crop
rotation, land preparation and other similar practices can also play
an important role in pest and disease control, but they are not
the major focus of this contribution. The management strategies
considered are regulated by government policies.Many of the reg-
ulatory policies have direct cost eﬀects such as the prior approval
of management options increasing the costs of the developer,
the restrictions on the scope of management options such as tim-
ing and/or quantities of pesticide use increasing the costs of the
user; others indirectly via labor laws, environmental regulations,
nature conservation policies and more. These regulatory policies
while increasing costs are also expected to provide additional
social beneﬁts justifying the additional costs.1 These beneﬁts in
most cases include potential damage costs avoided.
In recent years a debate about the appropriate level of regu-
lations has emerged driven by the debate about the introduc-
tion of genetically modiﬁed organisms (GMOs),2 new plant breed-
ing technologies for pest management,3 and biological control
options.4 The debate is not only limited to those mentioned, but
also applies to other pest and disease management strategies.
Many economists as well as other stakeholders are concerned
about the recent regulatory policy developments.5,6 They have
increased the research, approval, and application costs with-
out often providing additional beneﬁts justifying the additional
costs. In some cases they have even had negative implications
for the environment, industry structure and innovations in pest
management strategies.2 The latter is particularlyworrisomeas the
challenges posed by climate change require innovative solutions
for adaptation.
In this contribution the regulations of pest and diseasemanage-
ment will be discussed from an economic perspective. The recent
developments in the European Unionwill be addressed and possi-
bilities for improving regulatory policies discussed. This is not only
relevant for the caseof theEuropeanUnionbut also for other coun-
tries suchas theUnitedStates and those that follow, often formany
good reasons, European Union policies.
The contribution is organized as follows: ﬁrst the economics for
regulating pest and disease management will be discussed and
based on that, appropriate regulatory approaches will be derived
and contrasted with current regulatory policies before providing
suggestions for improvements.
2 REGULATING PESTMANAGEMENT
The regulation of pest and disease management can be justiﬁed
if the additional regulatory costs generate a large enough amount
of additional social beneﬁts. Private beneﬁts and costs generated
matter at farm level mainly to the farmer. Depending on the local
agro-climatic conditions including soils and landscape and the
economic environment, farmers will use diﬀerent pest and disease
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management strategies. Those management strategies will not
only diﬀer by crop, but they will also diﬀer by crop and farm.
At farm level the optimal control level is where the marginal pri-
vate beneﬁts equal the marginal private costs. Regulatory inter-
vention from an economic perspective is justiﬁed if additional
costs arise that the farmer does not take into consideration and
havenot yetbeenpricedby currentpolicies.7 Thepresenceof addi-
tional non-private costs does not imply that the use of a pest and
diseasemanagement strategy should be reduced to zero. The sim-
ple reason is that the pest anddiseasemanagement strategies also
generate additional beneﬁts, for example, in the form of higher
yields, yield quality and reduced input use or some combination
thereof. The observation that a pesticide causes environmental
damages does not per se justify a ban. The reduction in environ-
mental damages needs to be compared with the additional costs
in the form of reduced private and non-priced external beneﬁts to
justify a ban or a constraint on use.1
That a pest and disease management strategy is used in the ﬁrst
place already tells us that it generates beneﬁts at farm level – why
would the farmer otherwise use it? – and hence, policy interven-
tions changing use result in additional costs at farm level.
Modelling the economic beneﬁts of pest and disease manage-
ment strategies at farm level has to take into consideration that
pest anddiseasemanagement is a damage control strategy.8 Dam-
age control is not a yield increasing strategy such as, for example,
an increase in fertilizer use. This is shown in Figure 1,which is a sim-
pliﬁed illustration of the relationship between a damage reducing
and a yield increasing input such as fertilizer, holding everything
else constant. Damage control reduces the diﬀerence between
actual and potential yield. This is equivalent to a move from point
a in Figure 1 closer to point b’. Overall, damage control moves
the realized yield function closer to the potential yield function.
Changes in fertilizer use are a movement along the yield func-
tion. The optimal level for fertilizer use, ceteris paribus, in Figure 1 is
where themarginal product of fertilizer, the slope of the yield func-
tion, is equal to the fertilizer price, product-price ratio. In principle,
if fertilizer and product are priced according to the opportunity
costs principle, the optimal use not only reﬂects technical, but also
allocative eﬃciency.
The diﬀerence between damage reducing and yield increasing
inputs has implications for the economic model to be used for
identifying the optimal level of damage control. In the case of pest
and disease management a production function modelling pest
and disease management as a damage control input should be
applied where pest and disease management reduces damages,
i.e. yield losses. Otherwise, the optimal level of pest and disease
damage control will be overestimated while modelling pest man-
agement as a yield increasing strategy.8 Further, expenses for pest
and disease control are sunk costs. If uncertainty over the suc-
cess of pest and disease damage control strategies in the form of
incomplete knowledge about future pest and disease pressure is
addedand timingof pest anddisease control is ﬂexible, this further
reduces optimal intensity of pest control.9
The increase in actual yield as a result of successful damage con-
trol, often implies that the optimal level of yield increasing inputs
such as fertilizer also increases. This is indicatedby thediﬀerence in
fertilizer input between point A and B on the horizontal axis (Fig. 1)
and amove from point b’ to b along the potential yield function.10
This is relevant for cases where additional use of fertilizer might
be an obstacle, often observed for many developing countries,
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Figure 1. Changes in damage control on yield and optimal fertilizer use.
Note: the yield functions show the change in yield with an increase in
fertilizer use, related to one fertilizer technology such inorganic nitrogen or
organic nitrogen, holding everything else such as soil quality constant. The
potential yield function illustrates the yield that canbeachievedwithout any
damages due to pest and diseases. The actual yield function illustrates the
yield achieved considering pest and diseases. The increased yield function
illustrates the eﬀect a ‘new variety’ using fertilizer more eﬃciently. The
straight lines are the constant fertilizer price/product price ratios. The
points a, b, and c show the optimal level of fertilizer use given the price
ratio.
be realized, nevertheless a movement from a to b’ can be possi-
ble. Further, if new technologies move the potential yield func-
tion upwards, for example, nitrogen ﬁxing plants, the economic
beneﬁts of pest and disease management increase as the poten-
tial losses increase. This illustrated by the diﬀerence betweenpoint
a and point c in Figure 1. Hence, potential yield increasing tech-
nologies increase the demand for pest and disease management
or, to put it the other way around, the adoption of potential yield
increasing technologiesmight be limited by the availability of pest
and disease management strategies.
While the above is a somewhat simpliﬁed synopsis about the link
between damage control and yield increasing inputs as in reality
increase in the eﬃciency of fertilizer use and up-take, drought
tolerance and more complicate the eﬀects of damage control and
fertilizer use on yield. Nevertheless, the major eﬀects sketched, i.e.
damage control has an eﬀect on the use of other input factors and
vice versa, still holds.10
In summary, a ban or additional constraints on the use of pest
and disease management strategies practiced by farmers results
in additional costs at farm level and related income losses. This,
while widely recognized in the scientiﬁc literature,11 is often not
suﬃciently considered in policy debates over regulating pest
management. The discussion about the ban of broad-spectrum
herbicides such as glyphosate serves as a point in case. The
debate became highly politicized with accusation about biases in
the assessment made by several stakeholders being involved.12
What has been less considered within the debate is that the
use of glyphosate provides several beneﬁts to farmers as well
as society. The technology simpliﬁes weed management, highly
appreciated by farmers,13,14 reduces environmental damage in
no-till agriculture due to reduced soil erosion and as alterna-
tive weed management strategies often rely on herbicides with
a higher environmental impact quotient,15,16 reduces greenhouse
gas emission due to less tillage,15,16 and can reduce herbicide use
on the following crop.16 For sure, there are costs, such as the
Pest Manag Sci 2019; 75: 578–582 © 2018 Society of Chemical Industry wileyonlinelibrary.com/journal/ps
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evolution of glyphosate resistant weeds, requiring more appro-
priate weed management strategies, however not unique to
glyphosate but a general attribute of herbicides,17 but hardly
justifying a ban from an environmental, as well as economic point
of view.18,19
The case of glyphosate raises the question of how to assess the
beneﬁts and costs taking into consideration potential irreversible
eﬀects, an argumentoften raisedbygroups critical towards theuse
of glyphosate.20 One possibility is to assess the beneﬁts and costs
under uncertainty and irreversibility by identifying the economic
threshold level that should not be passed. This has been called in
the literature theMaximum Incremental Social Tolerable Irreversible
Costs.21 The threshold level can be used to check if evidence sug-
gests that this threshold level could be passed. An application
to the introduction of herbicide resistant sugar beets and maize
in the European Union shows that there are substantial doubts
that the threshold levels will be reached. For the case of herbi-
cide resistant maize, irreversible costs have to be in the order of
approximately 25 million Euro per year in 2005 values for France
and for the caseof herbicide resistant sugarbeets of approximately
163 million Europer year in 2004values for thewhole EU to justify a
delay in approval froman economic perspective.21,22 Nevertheless,
substantial regional diﬀerences can exist.23
These values also provide an indication about the annual
beneﬁts lost by delaying the approval. Considering that those
crops have not been introduced but could have been by the
mid-2000s shows substantial annual economic beneﬁts foregone.
Assessments for major crops at the world level conﬁrms that the
delays in approval can be substantial.24 While one might argue
that this does not matter that much for the European Union, a
well-developed and wealthy region, this can hardly be argued for,
for the case of developing countries.25 Many more studies show
that pest management using transgenic crops generate substan-
tial economic as well as environmental beneﬁts.26–28 Those are
foregone by delays in approvals or bans in countries not adopting
the technology in crop production.
3 THE APPROVAL OF PESTMANAGEMENT
STRATEGIES
Almost all pest management strategies require approval prior
to use. The approval takes time and can be very costly. Time
and costs vary by jurisdiction5,6,29,30 and for the case of the Euro-
peanUnionare alsohighlypoliticized including transgenic crops,31
biological control methods5 or pest management of invasive
species.32 As mentioned above the approval procedures delay
access to the technology, resulting in foregone beneﬁts.25,33
The approval processes in the European Union for pest and dis-
ease control strategies not only includes the risk assessment, done
byMember States and the European Food Safety Authority (EFSA),
but also the so called risk management phase where expert com-
mittees assess and vote on dossiers prepared by the European
Commission based on the risk assessment.5,6 Studies done for the
approval of transgenic crops in the EU show the risk management
step takes on average 594 days6 and for microbial biological con-
trol agents (MBCAs) on average 278 days.5 In many other jurisdic-
tions this step is not included in the approval process. Avoiding this
step at EU level can already speed-up approval without compro-
mising safety. A reform of the approval processmore closely to the
one for food under the General Food Law could be one of the pos-
sibilities. This would allow moving from maximum harmonization
towards minimum harmonization within the European Union and
providemore ﬂexibility formember states to approve pest anddis-
ease control strategieswithout compromising on internalmarkets.
A solution recently discussed also for the approval of new plant
breeding technologies.34
For the case of MBCAs a comparison with the United States
shows the overall approval process in the EU takes on aver-
age additional 532 days, including the risk management step of
278 days. The remaining diﬀerence suggests possibilities for fur-
ther reducing the length in approval time and related costs exist.
Additional possibilities for streamlining the risk assessment as
pointed out by lobby organizations and others include a more
science-based approach, streamlining the approval process, and
providing more ﬂexibility within the approval system.35–38
Further, the bias in the risk assessment in the EU, butmany other
countries as well, by concentrating only on risks and not consid-
ering the incremental beneﬁts of a new pest and disease man-
agement strategy creates an additional hurdle by either reducing
strategies being developed that might otherwise be beneﬁcial, or
increasing the research and development costs of applicants to
comply with approval requirements. From an economic perspec-
tive this generates additional costs that can be enormous, esti-
mates range between 53 000 and 15 million per trait for a trans-
genic crop, while industry reports much higher numbers.30,35 Sim-
ilar costs can be expected for the approval of biological control
agents.
The approval process itself is not only costly for the companies
involved30 but has also implications for the market structure of
the pest management sector.39 The approval costs act as a kind
of sunk costs discriminating against smaller companies reducing
overall competition within the sector by reducing market entry.
The approval costs are not only an issue for small and medium
sized companies. The recent mergers of Syngenta and China
National Chemical Corporation (ChemChina), DOW and Dupont,
and Bayer and Monsanto are examples. The mergers are driven
by expected synergies reducing research and development as
well as operational costs and are better prepared to comply with
high approval costs.39 Ironically, several societal groups calling for
high ex-ante regulatory policies are also concerned about industry
concentration,40 while the demand for those ex-ante regulatory
policies supports industry concentration.
Many economists have long argued that not only ex-ante regu-
latory standards are a tool, but also ex-post liability, for address-
ing safety issues.41–43 Ex-post liability allows holding developers
of a new technology liable for potential damages. This provides
incentives for the developer of the technology to act carefully to
avoid liability without implementing mandatory ex-ante regula-
tory standards. Still, it needs to bementioned that ex-post liability
has some shortcomings. The person or the company represented
by that person being held liable,might not have a suﬃciently large
amount of resources available for the damages to be compen-
sated. Companies have been observed to ﬁle for bankruptcy for
avoiding compensation payments.43 Also, legal systems are not
always equal. Large corporations are often able to hire the best
lawyers while the opposite party might not – the deep pocket
argument. Further, judges might be biased as well.43
Despite the problems using ex-post liability as a regulatory tool,
a number of possibilities exist to address these shortcomings
as well. They include compensation funds, insurance systems,
and improvements in the legal systems. Civil law countries, for
example, such as the majority of European Union member states,
are less vulnerable to the deep pocket argument in comparison
to common law countries such as the United States.43 Further,
wileyonlinelibrary.com/journal/ps © 2018 Society of Chemical Industry Pest Manag Sci 2019; 75: 578–582
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many of the potential damages being mentioned related to new
pest and disease management strategies are rather hypothetical
and often less pronounced in comparison to currently practiced
pest and disease management strategies reducing the possibility
of ex-post liability.2 The design of ex-post liability in this case
becomes more important.
The use of ex-post liability has not received enough attention in
the current debates on the approval of new pest and diseaseman-
agement strategies. Concerns about new pest and disease man-
agement strategies are often related to potential risks only. The
current debate about genome editing serves as a case.34 Genome
editing as well as many other technologies allows one to address
a number of important challenges for pest and disease man-
agement. Important examples include zoonotic diseases such as
malaria, Zika virus disease, or trypanosomes and invasive species
such as the fall armyworm in Africa, citrus greening disease in the
United States or the Western Corn Rootworm in Europe. The fall
army worm invasion in Africa in 2016 and 2017 serves as a point
in case,44 where, for example, gene driven technologies can pro-
vide solutions with less negative implications for the environment
in comparison to solutions based on insecticides and herbicides.45
A case has been put forward to the Court of Justice of the Euro-
pean Union (CJEU), where the question had been raised whether
herbicide resistant plants developed by using modern forms of
mutagenesis should be considered GMOs or not according to the
Directive 2001/18 EC.34 The CJEU decided that crops developed
by using new plant breeding technologies applying mutagenesis
techniques developed after 2001will be consideredGMOs accord-
ing to the EUdeﬁnition, will fall under theDirective 2001/18EC and
hence be regulated as GMOs according to EU law. The ruling and
the following legal acts will be important for the development of
new pest and disease management strategies. Depending on the
translation of the judgment into legal acts,46 approval costs will
be higher or lower with direct implications for the incentives to
invest in new pest and disease management strategies. The ruling
will aﬀect a wide range of pest and disease-management strate-
gies including biological control methods. In particular, biological
control strategies can beneﬁt from gene editing tools as screening
of possible control agents and translation into control strategies
can be simpliﬁed also to the beneﬁt of organic agriculture.47 Sup-
porters of using these new technologies, nevertheless, have been
heavily criticized.48
4 CONCLUSION
The swelling regulation of pest management strategies in the
European Union and other parts of the world has increased
the costs of agricultural production. In many cases the addi-
tional costs are not justiﬁed by additional beneﬁts generated. One
among other reasons is that the debate has become highly politi-
cized and less based on facts. The increase in costs has negative
implications for the development of new pest and disease man-
agement strategies. First, the increase in investment costs require
a higher level of beneﬁts to justify investment. As a result, less pest
and disease management strategies will be developed. Second,
the higher investment costs discriminate against smaller compa-
nies by making it more diﬃcult to enter the market. As a result,
a smaller number of companies will enter the market reducing
the number of solutions developed.
A number of possibilities exist to reduce the approval costs. First,
the length in approval time can be shortened by streamlining the
approval procedures without compromising on safety. In the EU
the risk management step at EU level can be dropped and directly
delegated to Member States. At international level approval pro-
cesses can be harmonized to reduce potential frictions in inter-
national trade. Once the safety of a new product has been estab-
lished, for example, it should receive world-wide approval for pro-
cessing and consumption (where applicable).
Second, approval procedures should not only assess potential
risks but also consider potential beneﬁts and thereby increasing
the range of possible solutions. The increase in range in possible
solutions will also provide opportunities to develop better pest
and diseasemanagement solutions for awider range of crops. This
will increase crop biodiversity and contribute to make agriculture
more resilient to climate change.
Third, regulatory policies should also consider ex-post liability as
a regulatory tool to reduce ex-ante approval costs. Many new pest
and disease control options have risk proﬁles not diﬀerent from
already approved control options. Those should be immediately
approved and the remaining potential risks covered by ex-post
liability. The private sector developing those control options can
be asked to develop compensation funds to increase trust in
ex-post liability.
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